Zhenling Q. Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Comparative efficacy and safety of systemic therapies in transplant-eligible and ineligible relapsed/refractory large B-cell lymphoma: a Bayesian network meta-analysis.
Journal: Translational cancer research
Published: March 23, 2026
Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.
Journal: Annals of hematology
Published: February 03, 2026
Real-world comparison of BTK inhibitors and lenalidomide as first-line maintenance in primary CNS lymphoma: a multi-center retrospective study.
Journal: Journal of neuro-oncology
Published: January 29, 2026
The Prognostic Value of Integrating Copy Number Alteration Profiles in NPM1-Mutated Acute Myeloid Leukemia: An Exploratory Study.
Journal: The application of clinical genetics
Published: August 07, 2025
Preliminary evidence for the integration of CNAs, CN-LOH and mutational profiles into the prognostic stratification of elderly patients with NPM1-mutated acute myeloid leukemia.
Journal: Oncology letters
Published: July 21, 2025
Treatment-free remission in chronic myeloid leukaemia patients with accelerated phase or tyrosine kinase inhibitor therapy failure.
Journal: British journal of haematology
Published: June 14, 2025
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 study.
Journal: Signal transduction and targeted therapy
Published: May 19, 2025
Clinical outcomes and therapeutic modalities in older Chinese patients with MCL: a multi-center real-world retrospective study.
Journal: Annals of medicine
Published: March 28, 2025
Identification of Copy Number Alterations From Shallow Whole-Genome Sequencing in Multiple Myeloma.
Journal: Hematological oncology
Published: October 16, 2024
Last Updated: 09/26/2026